Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Debridement, Antibiotics and Implant Retention (DAIR) for Infected Total Hip Arthroplasty- Does the Operative Approach Influence the Functional Result?

NCT03161990 is registered in ClinicalTrials.gov with University Hospital, Akershus as lead sponsor.

NCT NCT03161990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03161990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Debridement, Antibiotics and Implant Retention (DAIR) for Infected Total Hip Arthroplasty- Does the Operative Approach Influence the Functional Result?
Lead sponsor
University Hospital, Akershus
Phase
Observational
Overall status
Completed
Start date
April 23, 2018
Completion date
November 17, 2018
Enrollment
226 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthroplasty complications, hip prosthesis infection